Clinical Trial Update: MARS - Monitored Atherosclerosis Regression Study [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update for the Monitored Atherosclerosis Regression Study (MARS) sponsored by Merck Sharp & Dohme LLC, evaluating treatment for ather…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Atherosclerosis, Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED